[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
[ Fri, Jun 07th 2024 ]: WOPRAI
Ed Arce Reiterated (ABUS) at Strong Buy and Held Target at $5 on, Jun 7th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Ed Arce of HC Wainwright & Co., Reiterated "Arbutus Biopharma Corporation" (ABUS) at Strong Buy and Held Target at $5 on, Jun 7th, 2024.
Ed has made no other calls on ABUS in the last 4 months.
There are 2 other peers that have a rating on ABUS. Out of the 2 peers that are also analyzing ABUS, 0 agree with Ed's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Ed
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $4 on, Wednesday, June 5th, 2024
- Roy Buchanan of "JMP Securities" Reiterated at Buy and Held Target at $4 on, Thursday, April 4th, 2024